Pulmonary arterial hypertension: current therapeutic strategies

被引：0
|
作者：
Aniket Puri
Michael D McGoon
Sudhir S Kushwaha
机构：
[1] A Puri is a Senior Research Associate in Cardiology at King George's Medical University,
[2] Lucknow,undefined
[3] India.,undefined
[4] MD McGoon is Professor of Medicine and Director of the Pulmonary Hypertension Clinic at Mayo Clinic.,undefined
[5] SS Kushwaha is an Associate Professor of Medicine and Consultant in Cardiology at Mayo Clinic,undefined
[6] Rochester,undefined
[7] MN,undefined
[8] USA.,undefined
来源：
Nature Clinical Practice Cardiovascular Medicine | 2007年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Pulmonary arterial hypertension (PAH) was once a lethal condition. As the number of therapeutic options available has risen, however, the treatment of PAH has evolved considerably. In this Review, Aniket Puri, Michael McGoon and Sudhir Kushwaha consider the current knowledge of the pathogenesis of PAH in relation to presently available and novel emerging therapies, including combination therapy, that hold promise for treatment as well as disease modification.
引用
收藏
页码：319 / 329
页数：10
相关论文
共 50 条
  • [1] Pulmonary arterial hypertension: current therapeutic strategies
    Puri, Aniket
    McGoon, Michael D.
    Kushwaha, Sudhir S.
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2007, 4 (06): : 319 - 329
  • [2] Current Therapeutic Approaches to Pulmonary Arterial Hypertension
    Galie, Nazzareno
    Palazzini, Massimiliano
    Leci, Enri
    Manes, Alessandra
    REVISTA ESPANOLA DE CARDIOLOGIA, 2010, 63 (06): : 708 - 724
  • [3] Current treatment strategies for pulmonary arterial hypertension
    Lee, SH
    Rubin, LJ
    JOURNAL OF INTERNAL MEDICINE, 2005, 258 (03) : 199 - 215
  • [4] The current approach into signaling pathways in pulmonary arterial hypertension and their implication in novel therapeutic strategies
    Jasinska-Stroschein, Magdalena
    Orszulak-Michalak, Daria
    PHARMACOLOGICAL REPORTS, 2014, 66 (04) : 552 - 564
  • [5] Pulmonary arterial hypertension associated with systemic sclerosis: Current diagnostic approach and therapeutic strategies
    Olga Vera-Lastra
    Mateo Porres-Aguilar
    World Journal of Rheumatology, 2012, (02) : 12 - 20
  • [6] The current approach into signaling pathways in pulmonary arterial hypertension and their implication in novel therapeutic strategies
    Magdalena Jasińska-Stroschein
    Daria Orszulak-Michalak
    Pharmacological Reports, 2014, 66 : 552 - 564
  • [7] Idiopathic Pulmonary Arterial Hypertension: Evolving Therapeutic Strategies
    Kanwar, Manreet
    Raina, Amresh
    Passineau, Michael
    Benza, Raymond
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 38 (05) : 606 - 618
  • [8] Current and Future Therapeutic Targets for Pulmonary Arterial Hypertension
    Fraidenburg, Dustin
    Yuan, Jason
    HIGH ALTITUDE MEDICINE & BIOLOGY, 2013, 14 (02) : 134 - 143
  • [9] Current therapeutics and practical management strategies for pulmonary arterial hypertension
    Agarwal, Richa
    Gomberg-Maitland, Mardi
    AMERICAN HEART JOURNAL, 2011, 162 (02) : 201 - 213
  • [10] Recent advances and future perspectives in therapeutic strategies for pulmonary arterial hypertension
    Yao, Atsushi
    JOURNAL OF CARDIOLOGY, 2012, 60 (5-6) : 344 - 349
12345